Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company
Stock Information for Aytu BioPharma Inc.
Loading
Please wait while we load your information from QuoteMedia.